Cleanroom facility within existing premises for supply of small volume API quantities: Initiated manufacturing of 8 peptide APIs and 2 semi synthetics API from August 2022 (FY23) FDA Approval is available.
Established in 2011, as a private limited company registered under Companies Act, 1956, we are quickly growing towards creating a vast impact on the healthcare industry.